Xeris Biopharma Holdings, Inc. (XERS)
NMS – Real vaqt narxi. Valyuta: USD
7.69
+0.29 (3.92%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
7.66
-0.03 (-0.39%)
Bozordan keyin: Jun 26, 2026, 6:15 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
7.69
+0.29 (3.92%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
7.66
-0.03 (-0.39%)
Bozordan keyin: Jun 26, 2026, 6:15 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $258.6M naqd pul zahiralaridan ($111.8M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $251.7M jami joriy majburiyatlardan $118.6M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (19.9) tarmoq o'rtachasidan ancha yuqori bo'lib, haddan tashqari leverajni aks ettiradi
Foiz qoplash koeffitsiyenti (1.1x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Kompaniya ijobiy erkin pul oqimi $9.5M generatsiya qiladi, moliyaviy salomatligini qo'llab-quvvatlaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 2.12 | 2.52 | 10 | |
| Tezkor likvidlik nisbati | 1.50 | 1.78 | 7.0 | |
| Qarz/Kapital nisbati | 19.87 | -0.80 | 2.0 | |
| Qarz/Aktivlar nisbati | 0.66 | 0.73 | 3.0 | |
| Foiz to‘lov qoplami | 1.15 | -13.90 | 4.0 | |
| O‘rtacha ball | 5.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 110M | 164M | 203M | 292M | 315M |
| Yalpi foyda | 77M | 124M | 155M | 238M | 260M |
| Operatsion daromad | -80M | -44M | -34M | 25M | 36M |
| Sof foyda | -95M | -62M | -55M | 554K | 12M |
| EBITDA | -68M | -31M | -21M | 38M | 49M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 26.31 | 221.43 | 10 |
| Keyingi chorak | 36.24 | N/A | 5.5 |
| Joriy yil | 32.26 | 4425.82 | 10 |
| Keyingi yil | 22.5 | 151.48 | 10 |
| O‘rtacha ball | 8.9 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -3.11 | -79.83 | -83.32 | -51.56 | 1.0 |
| Yil/Yil | 38.27 | 124.23 | 116.67 | 195.03 | 10 |
| 3 yil o‘rtacha | 38.76 | 49.05 | 51.45 | 83.33 | 10 |
| 5 yil o‘rtacha | 76.26 | 27.08 | 47.35 | 44.72 | 10 |
| O‘rtacha ball | 7.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |